The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 30, 2011

Filed:

Jan. 30, 2007
Applicants:

Genevieve Choquet-kastylevsky, Francheville, FR;

Yohan Demont, Lille, FR;

Hubert Hondermarck, Villeneuve d'Ascq, FR;

Inventors:

Genevieve Choquet-Kastylevsky, Francheville, FR;

Yohan Demont, Lille, FR;

Hubert Hondermarck, Villeneuve d'Ascq, FR;

Assignees:

Biomerieux, Marcy l'Etoile, FR;

University des Sciences et Technologies de Lille, Villeneuve d'Ascq, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/68 (2006.01); A61K 35/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention concerns a method for in vitro diagnosis of cancer, in particular breast, thyroid or lung cancer, which consists in determining the presence of ProNGF in a biological sample derived from a patient suspected of suffering from cancer, in particular breast, thyroid or lung cancer. Said method may be used for early diagnosis, screening, therapeutic follow-up, prognosis and for diagnosing relapses in cancer and in particular breast, thyroid or lung cancer. The present invention also concerns the use of a ProNGF inhibitor for preparing a drug, said drug being in particular useful for blocking remote dissemination and cell invasion in patients suffering from cancer, in particular breast, thyroid or lung cancer. The invention is applicable in the field of diagnosis and therapeutics.


Find Patent Forward Citations

Loading…